SC
TMBR

Searle & Co’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Searle & Co’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200
Closed -$4K – 164
2021
Q4 		$4K Hold
200
– – ﹤0.01% 160
2021
Q3 		$9K Hold
200
– – ﹤0.01% 148
2021
Q2 		$12K Buy
+200
New +$14.1K ﹤0.01% 147

Other funds holding TMBR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Searle & Co's TMBR Position: Q1 2022 in Review

Searle & Co sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2022, closing a stake of 200 shares — an estimated $4K sold.

Searle & Co first reported a position in TMBR in Q2 2021 and held it in 3 quarters. The position peaked at $12K in Q2 2021. 15 funds tracked by Wall St. Rank hold TMBR as of Q1 2022.

  • Searle & Co reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
  • Searle & Co sold 200 Timber Pharmaceuticals, Inc. shares in Q1 2022, an estimated $4K.
  • Searle & Co first reported a position in Timber Pharmaceuticals, Inc. in Q2 2021 and held it in 3 quarters.
  • Searle & Co's Timber Pharmaceuticals, Inc. position peaked at $12K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2022.

Based on Searle & Co's 13F filing for Q1 2022, filed 10 May 2022.